Adaptive Biotechnologies director Peter M. Neupert disposes of 124,690 common shares for $3.14 million
ADPT•Director reports option exercise and share sales
- Adaptive Biotechnologies director Peter M. Neupert reported option exercise and share sales dated Aug. 17, 2026.
- He exercised 15,000 stock options at $6.32, then sold 124,690 shares at weighted-average prices near $25.10-$25.23.
- Directly held 130,625 shares following the transactions.
